Skip to main content

Table 4 Associations between other patient factors and hypertension control

From: Patient-level factors influencing hypertension control in adults in Accra, Ghana

VariableControlled BP  
NoYesχ2p-value
n(%)n(%)  
Comorbidity
 No59(62.11)36(37.89)15.2969< 0.001
 Yes217(81.89)48(18.11)  
Diabetes
 No147(74.62)50(25.38)1.01950.313
 Yes129(79.14)34(20.86)  
CKD
 No262(75.72)84(24.28) 0.047c
 Yes14(100.00)0(0.00)  
Dyslipidaemia
 No225(74.01)79(25.99)7.69210.006
 Yes51(91.07)5(8.93)  
Stroke
 No262(76.83)79(23.17)0.09970.752
 Yes14(73.68)5(26.32)  
Pills taken for comorbidity
 1–284(80.77)20(19.23) 0.725c
 3–6130(83.87)25(16.13)  
7–133(75.00)1(25.00)  
Non-Prescribed Medb.
 No209(76.56)64(23.44)0.00760.930
 Yes67(77.67)20(22.99)  
Length of diagnosis
 121(63.64)12(36.36)11.92930.008
 2–5112(84.21)21(15.36)  
 6–1091(78.45)25(21.55)  
 21–4052(66.67)26(33.33)  
No. BP pills taken per day
 1–285(64.89)46(35.11)15.978< 0.001
 2–4191(83.41)38(16.59)  
Total276 (76.67)84 (23.33)  
  1. n: Frequencies,%:row percentages
  2. a Co-morbidity was defined as the presence of diabetes, chronic kidney disease or dyslipidaemia
  3. bNon-prescribed medication refers to any drug the patient is currently taking that is not prescribed by the attending physician
  4. c Fishers’ exact value